16 seasons of data reveal stocks beating earnings forecasts gain 5.2% on results day and often continue trending higher for ...

Figma's spectacular IPO has cranked excitement around Canva's potential to go public in a US market with a wild appetite for tech stars.

Why dividend idiosyncrasies lend themselves so well to active management, and what a great dividend-paying company looks like ...

In today’s market, income investing is no longer just about dividends and deposits. With inflation, interest rate shifts, and ...

Plus, PIMCO's Robert Mead explains why the outlook for core bonds is looking particularly attractive due to high starting ...

ASX holds steady ahead of reporting season, rate cut odds firm, global earnings mixed, and Boss Energy dives on cost blowout.

When markets soar, fear sets in. But ditching a regular investing strategy at the top could sabotage long-term success.

Elston’s Bruce Williams discuss ResMed's results and margin momentum, and whether the stock still deserves a buy rating.

Not sure where to start this ASX FY25 reporting season? NAOS analyses keywords in earnings call transcripts to reveal the ...

Everyone hates the idea of losing money on shares, but can the fear hold you back from a lifetime of financial optimisation?